[Home](https://github.com/mm80843/T3.5/blob/pages/index.md) >> Class: [Risk](https://github.com/mm80843/T3.5/tree/pages/docs/Risk/index.md) >> Individual ID:PBN__Risk_17685 

# __Ai-facilitated drug discovery for covid-19 treatment__

## Articles mentionning the risk

* [Naseem_exploring_2020](https://github.com/mm80843/T3.5/blob/pages/Article/PBN__Article_636.md)

## Mitigations of this risk

* [Combined use of ai with traditional drug discovery methods, rigorous validation and testing of ai-generated results](https://github.com/mm80843/T3.5/blob/pages/Mitigation/PBN__Mitigation_19645.md)

## Name of the risk

Potential for ineffective drug discovery due to limitations of AI-based testing

## People affected by this risk

* [Drug developers](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_1196.md)
* [Pharmaceutical researchers](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_14033.md)

## Stakeholders who can mitigate this risk

* [Pharmaceutical research institutions and drug development companies](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_14034.md)

## Technologies linked to the risk

* [Integration of ai with drug discovery processes](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_20081.md)
* [Validation using clinical trials and laboratory testing](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_20082.md)

## This Risk belongs to this RiskGroup

* [Technological risks](https://github.com/mm80843/T3.5/blob/pages/RiskGroup/PBN__RiskGroup_8.md)

## This Risk belongs to this RiskSubgroup

* [Artificial intelligence and machine learning risks](https://github.com/mm80843/T3.5/blob/pages/RiskSubgroup/PBN__RiskSubgroup_50.md)

